CareEvolve.com, Inc., a wholly-owned subsidiary of BioReference
Laboratories, Inc (NASDAQ: BRLI), and ZoomMed USA have announced an
agreement which will allow CareEvolve’s 30,000 provider users to access
e-prescribing using ZoomMed’s ZRx Prescriber service.
CareEvolve provides physician portals to clinical laboratories for use
by their provider clients for Computerized Physician Order Entry (CPOE),
electronic results storage, review and analytics. ZoomMed’s ZRx service
has been seamlessly integrated into the CareEvolve physician portal.
According to The Centers for Medicare and Medicaid Services (CMS)
website: “A prescriber's ability to electronically send an accurate,
error-free and understandable prescription directly to a pharmacy from
the point-of-care is an important element in improving the quality of
ZoomMed’s ZRx Prescriber has been certified by SureScripts for
Prescription Routing, Prescription Benefits and Medication History. It
meets government requirements for CMS’s eRx Incentive Program.
Electronic prescribing improves patient safety by eliminating errors
from handwriting illegibility, wrong dosing, missed drug interactions or
drug/allergy reactions. It also saves providers' time by automating the
transfer of new prescriptions to pharmacies and approving renewal
CareEvolve is a wholly-owned subsidiary of BioReference Laboratories,
Inc, and has been connecting laboratories to physicians since 1999.
CareEvolve’s Electronic Medical Record (EMR) connectivity solutions
deliver results to and accept orders from virtually every electronic
medical record on the market today. CareEvolve also provides an
Internet-based Computerized Physician Order Entry (CPOE) and results
reporting solution for clinical laboratory, pathology and radiology
outreach businesses. Patient Portal and e-Prescribing modules have
recently been introduced. CareEvolve's browser independent, cloud based
software is compatible with smart phones and tablets, giving providers
remote access to clinical information. The CareEvolve solution is used
by over 30,000 physicians every day.
About BioReference Laboratories, Inc.
BRLI is a clinical testing laboratory offering testing, information and
related services to physician offices, clinics, hospitals, employers and
governmental units. We believe that we are the fourth largest
full-service laboratory in the United States and the largest independent
regional laboratory in the Northeastern market. BRLI offers a
comprehensive list of laboratory testing services utilized by healthcare
providers in the detection, diagnosis, evaluation, monitoring and
treatment of diseases. BRLI primarily focuses on esoteric testing,
molecular diagnostics, anatomical pathology, women’s health and
correctional health care.
About ZoomMed USA
ZoomMed is a leader in e-prescribing. Their ZRx Prescriber delivers
e-prescribing simplicity for the provider and encourages compliance and
persistence in patients. It is a SureScripts certified application that
can be integrated with any Electronic Medical Record (EMR) application.
The Web application is compatible with wireless devices such as iPhone™,
iPad™, and Google Android™ based platforms. It also operates on Internet
connected workstations and laptop computers using Windows and Mac
operating systems. More than 30 million new prescriptions and renewals
are processed each year by ZoomMed products.
In addition to ZRx Prescriber, ZoomMed also offers a Clinical
Information Exchange platform between physicians and various other
stakeholders of the health sector, such as pharmacists, specialists,
pharmaceutical corporations, specialized clinics, health payers and
others. ZoomMed also offers Web based pharmacy management software.
ZoomMed USA is a wholly owned subsidiary of ZoomMed Inc. Founded in
2005, ZoomMed Inc., with corporate offices in Quebec and Ontario,
Canada, (symbol: ZMD) is a publicly traded company listed on the
Canadian TSX Venture Exchange.